🇺🇸 COVID-19 convalescent plasma in United States

430 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 200 reports (46.51%)
  2. Drug Ineffective For Unapproved Indication — 70 reports (16.28%)
  3. Drug Ineffective — 37 reports (8.6%)
  4. Covid-19 — 35 reports (8.14%)
  5. Maternal Exposure During Pregnancy — 18 reports (4.19%)
  6. Covid-19 Pneumonia — 17 reports (3.95%)
  7. Foetal Exposure During Pregnancy — 14 reports (3.26%)
  8. Bronchopulmonary Aspergillosis — 13 reports (3.02%)
  9. Death — 13 reports (3.02%)
  10. Exposure During Pregnancy — 13 reports (3.02%)

Source database →

Other Infectious Diseases approved in United States

Frequently asked questions

Is COVID-19 convalescent plasma approved in United States?

COVID-19 convalescent plasma does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for COVID-19 convalescent plasma in United States?

Lifefactors Zona Franca, SAS is the originator. The local marketing authorisation holder may differ — check the official source linked above.